Regulatory T Cells in Chagas' Disease
Author Information
Author(s): de Araújo Fernanda Fortes, Vitelli-Avelar Danielle Marquete, Teixeira-Carvalho Andréa, Renato Zuquim Antas Paulo, Assis Silva Gomes Juliana, Sathler-Avelar Renato, Otávio Costa Rocha Manoel, Elói-Santos Silvana Maria, Pinho Rosa Teixeira, Correa-Oliveira Rodrigo, Martins-Filho Olindo Assis
Primary Institution: Centro de Pesquisas René Rachou, FIOCRUZ, Belo Horizonte, Brasil
Hypothesis
The study investigates the role of regulatory T cells in different clinical forms of Chagas' disease.
Conclusion
Regulatory T cells may help control the immune response in Chagas' disease, particularly in patients with the indeterminate form.
Supporting Evidence
- Individuals with the indeterminate form of Chagas' disease have a higher frequency of regulatory T cells.
- Regulatory T cells may limit tissue damage during the immune response to Trypanosoma cruzi.
- IL-10 produced by regulatory T cells is effective in controlling disease development in indeterminate patients.
- Cardiac patients show a different regulatory mechanism that may not be sufficient to control disease progression.
Takeaway
Some special immune cells help people with Chagas' disease not get too sick, especially those who don't show symptoms.
Methodology
The review summarizes findings from various studies on Treg cells in Chagas' disease.
Limitations
The review is based on phenotypic data and lacks extensive functional studies due to the complexity of human immune responses.
Participant Demographics
The study discusses patients with different clinical forms of Chagas' disease, including indeterminate and cardiac forms.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website